UnipolSai Assicurazioni S.p.A.
UnipolSai Assicurazioni S.p.A. (FDIAY) Financial Performance & Income Statement Overview
Explore the financials of UnipolSai Assicurazioni S.p.A. (FDIAY), including yearly and quarterly data on income, cash flow, and balance sheets.
UnipolSai Assicurazioni S.p.A. (FDIAY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for UnipolSai Assicurazioni S.p.A. FDIAY financial performance.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $2.87B | $2.87B | $2.63B | $2.63B |
Cost of Revenue | $0.00 | $0.00 | -$3.58B | $0.00 |
Gross Profit | $2.87B | $2.87B | $6.21B | $2.63B |
Gross Profit Ratio | $1.00 | $1.00 | $2.36 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $143.50M | $143.50M | $139.50M | $139.50M |
Operating Expenses | $143.50M | $143.50M | $2.20B | $2.20B |
Total Costs & Expenses | $143.50M | $143.50M | $2.20B | $2.20B |
Interest Income | $0.00 | $0.00 | $0.00 | $57.00M |
Interest Expense | $0.00 | $0.00 | $114.00M | $0.00 |
Depreciation & Amortization | $0.00 | $0.00 | -$420.00M | -$420.00M |
EBITDA | $0.00 | $0.00 | -$63.50M | -$63.50M |
EBITDA Ratio | $0.00 | $0.00 | -$0.02 | -$0.02 |
Operating Income | $2.73B | $2.73B | $420.00M | $420.00M |
Operating Income Ratio | $0.95 | $0.95 | $0.16 | $0.16 |
Other Income/Expenses (Net) | -$2.45B | -$2.45B | -$41.50M | -$41.50M |
Income Before Tax | $279.50M | $279.50M | $378.50M | $378.50M |
Income Before Tax Ratio | $0.10 | $0.10 | $0.14 | $0.14 |
Income Tax Expense | $2.50M | $2.50M | $101.00M | $101.00M |
Net Income | $281.50M | $281.50M | $255.50M | $255.50M |
Net Income Ratio | $0.10 | $0.10 | $0.10 | $0.10 |
EPS | $0.39 | $0.39 | $0.36 | $0.36 |
Diluted EPS | $0.00 | $0.36 | $0.36 | |
Weighted Avg Shares Outstanding | $716.001M | $716.001M | $716.001M | $716.001M |
Weighted Avg Shares Outstanding (Diluted) | $0.00 | $0.00 | $716.00M | $716.00M |
Over the past four quarters, UnipolSai Assicurazioni S.p.A. demonstrated steady revenue growth, increasing from $2.63B in Q1 2024 to $2.87B in Q4 2024. Operating income reached $2.73B in Q4 2024, maintaining a consistent 95% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to $281.50M, with EPS at $0.39. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan